AstraZeneca
This role leads in silico design for biologic therapeutics across oncology, respiratory, and cardiovascular disease areas, leveraging AI and computational structural biology to advance the company's pipeline. The position involves building robust structural analytics workflows, integrating new computational capabilities, and collaborating with discovery and data scientists to optimize antibodies, VHHs, and other protein modalities. The role focuses on driving innovative design and optimization methods to enhance protein potency, specificity, and developability.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
43% above the average for this role